TRI is proud to join the Veeva R&D Summit as a Product Partner, showcasing our collaboration.
Appointment Announcement – Jamie Moss, Executive Chair
We’re excited to announce the appointment of Jamie Moss, new Executive Chair.
The Quality Issue – August 2025
Join our ICH E6(R3) live panel webinar, explore ACRO highlights, and connect with TRI this autumn.
5 Mistakes That Could Compromise Your Clinical Trial
Explore five common mistakes that can derail your clinical trial and how OPRA helps teams manage risk.
Modernizing Central Monitoring in Clinical Trials
Discover how TRI is transforming clinical research through smarter, data-driven solutions.
Driving Smarter Clinical Trials with RBQM
RBQM is redefining how clinical trials are designed, enabling smarter, more resilient research.
Collaborating Under ICH E6 (R3)
Explore how sponsors and CROs must rethink collaboration and embed quality into every layer of trial execution.
Why ICH E6 R3 Matters for Clinical Trials
Explore how E6 (R3) reshapes trial design, oversight, and culture, and why the industry must be ready to respond.
What is ICH E6 (R3)?
ICH E6 (R3) sets a new global benchmark for Good Clinical Practice, modernizing oversight with principle-based, risk-driven, and digitally enabled trial design.
The Quality Issue – July 2025
ICH E6(R3) is now effective in the EU, marking a pivotal shift in clinical trial oversight. This issue breaks down what it means and how to stay ahead.